Advertisement

Search Results for "Novosom Delivery"

03:28 EDT 21st May 2013 | BioPortfolio

Original Source: Novosom AG

Novosom AG has solved the major obstacle towards DNA therapeutics: Delivery of the therapeutic principle towards the cell interior. Novosom and its partners develop unique DNA based therapeutics in inflammation, oncology and liver diseases. In addition, the company is developing its own pipeline in autoimmune diseases. In 2007, the company plans to file two INDs with partners (oncology and liver diseases) and prepare two INDs for its own products (inflammation). DNA therapeutics comprise antisense, decoy an...

Matching Channels

Cesarean Delivery

Operative vaginal delivery

Normal Pregnancy Labor and Delivery

Drug Delivery - news, views, blogs

Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  Drug delivery technologies are patent protected formulat...

Immunocytokines

Although the human cytokines interleukin-2 (IL-2) and tumor necrosis factor (TNF) alpha are approved marketed for tumor therapy, their use is rather limited due to severe systemic side effects. Targ...

Matching News

Novosom: Strategies for a Novel Liposomal Delivery Company

In this exclusive interview, Fintan Walton talks to Elias Papatheodorou, CEO of novosom, about the company’s novel liposomal technology, and the potential applications of this technology. Elias expl...

Visiongain - 2013 Conferences

​7th Annual Drug Delivery Systems Conference - The Present and Future of the Drug Delivery Technologies Industry and Market overview: Advances in Biological Drug Delivery…peptides additionally exp...

Industry analysis in drug delivery partnering activity

Over 2000 drug delivery partnering deals have been announced between January and mid-March 2013, showing that drug delivery partnering is in good health, with numerous bigpharma companies actively par...

Drug Delivery Technologies Show Promise Of Improving Clinical Outcomes For Patients At Partnership Opportunities In Drug Delivery Conference

In an effort to remove barriers and embrace collaborations to get therapeutics to patients faster, pharmaceutical and biotech companies will listen to more than 25 drug delivery technology presentatio...

Polymers for pulmonary drug delivery book released by Smithers Rapra

Pulmonary drug delivery has been a rapidly expanding field, moving from the traditional propellant based metered dose inhaler delivery of small asthma drugs, to a broader landscape of new devices and...

Covagen Names Elias Papatheodorou Chief Business Officer

ZURICH-SCHLIEREN, Switzerland, April 15, 2013 /PRNewswire/ -- Covagen today announced the expansion of its senior management team with the appointment of Elias Papatheodorou as chief business off...

Recent Trends in Drug Delivery Partnering 2007 to 2012

Over 300 drug delivery partnering deals have been announced between January and mid-November 2012, showing that drug delivery partnering is in good health, with numerous bigpharma companies actively p...

MedPro signs license agreement for drug delivery platform

MedPro Safety Products has signed a letter of intent with a specialty pharmaceutical company for licensing its drug delivery platform, designed for safer medication delivery and blood collection.

Matching PubMed Articles

Fusion-Relevant Changes in Lipid Shape of Hydrated Cholesterol Hemisuccinate Induced by pH and Counterion Species.

Cholesterol hemisuccinate (CHEMS) is a protonable lipid that is frequently used for the construction of pH-responsive delivery systems. Such systems have a stable, lamellar phase at pH 7, but can form...

An ion switch regulates fusion of charged membranes.

Here we identify the recruitment of solvent ions to lipid membranes as the dominant regulator of lipid phase behavior. Our data demonstrate that binding of counterions to charged lipids promotes the f...

Hydrodynamic Gene Delivery and Its Applications in Pharmaceutical Research.

Hydrodynamic delivery has emerged as the simplest and most effective method for intracellular delivery of membrane-impermeable substances in rodents. The system employs a physical force generated by a...

Interview with Paul Ashton: sustained-release drug delivery to the eye.

Paul Ashton is President and Chief Executive Officer of pSivida (MA, USA), a provider of miniaturized, sustained-release drug-delivery products with a primary focus in ophthalmology. He also served in...

Immediate topical drug delivery by natural submicron injectors.

Transdermal delivery is an attractive but challenging solution for delivery of drugs. The sea anemone possesses a sophisticated injection system, which utilizes built-in high osmotic pressures. The sy...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement